Posted by H. Sandra Chevalier-Batik

The nation’s ongoing economic turmoil is also threatening the pharmaceutical industry with “unfamiliar challenges,” says Ronald Waife, president of Needham, Mass.-based clinical research consultancy Waife & Associates. Long discovery and product cycles have traditionally shielded pharmaceutical companies from the realities of layoffs and facility shutdowns that they’re now being forced to confront.